Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mixx Health & Wellness vs NowPatient

Mixx Health & Wellness
Graded #266

Lower grade

vs+2.700000000000003
NowPatient
Graded #217

Higher grade

The verdict

NowPatient takes it — 65.5/100 to 62.8/100.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMixx Health & Wellness +44
79
35
Dose & formulationNowPatient +53
40
93
Clinical oversightNowPatient +22
64
86
Labs & monitoringMixx Health & Wellness +9
63
54
FulfillmentEven
70
70
Contract termsEven
55
55
Mixx Health & Wellness · left barNowPatient · right bar

The numbers

MetricMixx Health & WellnessNowPatient
WeighScore62.8/10065.5/100
GradeCC
Scorecard rank#266#217
SemaglutideNot disclosed$1,349/mo (brand Wegovy)
TirzepatideNot disclosed$1,069/mo (brand Mounjaro, promotional rate)
Coverage44 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Mixx Health & Wellness

Graded #266 · C

Strengths

  • 44 jurisdictions enumerated in the public FAQ — confirm eligibility before intake
  • Operating LLC disclosed: Mixx Health and Wellness LLC (Wyoming law)
  • Named pharmacy partner: Promise Pharmacy, Palm Harbor FL, (727) 772-0500
  • Named founder: Dr. James David Lawrence III, MD, with a public origin story
  • $0 consultation fee — free intake and follow-ups

Where it loses points

  • Both medications are compounded semaglutide and tirzepatide — not FDA-approved brand drugs
  • Dose-tier pricing not available — /pricing and /products pages returned 404
  • No LegitScript, PCAB, or BBB trust badges visible
  • Wyoming governing-law clause — disputes adjudicated under Wyoming law regardless of your state
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
NowPatient

Graded #217 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard